Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Frances Wiseman, MRes, PhD, of University College London, London, UK, discusses how Down syndrome enhances amyloid-β deposition independently of an extra copy of APP. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK. Read more about this work here: https://www.ncbi.nlm.nih.gov/pubmed/29945247
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.